MedTrace Logo

Repeated Controlled Human Hookworm Infection

NCT03257072 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2020-11-18

No results posted yet for this study

Summary

Twenty-four healthy hookworm-naive volunteers will be exposed to 50 L3 Necator americanus larvae for a maximum of three times.

Conditions

  • Necator Americanus Infection

Interventions

BIOLOGICAL

50 Necator americanus L3 larvae

1x50 Necator americanus L3 larvae

BIOLOGICAL

100 Necator americanus L3 larvae

2x50 Necator americanus L3 larvae

BIOLOGICAL

150 Necator americanus L3 larvae

3x50 Necator americanus L3 larvae

Sponsors & Collaborators

  • Meta Roestenberg

    lead OTHER

Principal Investigators

  • Meta Roestenberg, MD. PhD. · LUMC

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-10
Primary Completion
2018-08-30
Completion
2018-08-30

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03257072 on ClinicalTrials.gov